Efficacy and safety of targeted therapy for metastatic HER2-positive breast cancer in the first-line treatment: a Bayesian network meta-analysis

PURPOSE: Numerous HER2-targeted therapy clinical trials have demonstrated efficacy and safety in the first-line treatment of metastatic breast cancer (MBC). However, the direct or indirect comparison of these drugs is unclear. This network meta-analysis can solve this issue to some extent. MATERIALS...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Fubin, Zhang, Tingting, Yin, Fang, Liu, Cun, Zhuang, Jing, Qi, Lingyu, Wang, Xue, Li, Jia, Wang, Lu, Tian, Jinhui, Sun, Changgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6362967/
https://www.ncbi.nlm.nih.gov/pubmed/30774382
http://dx.doi.org/10.2147/OTT.S187739

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6362967/
https://www.ncbi.nlm.nih.gov/pubmed/30774382
http://dx.doi.org/10.2147/OTT.S187739

Ejemplares similares